xx, 251 pages : illustrations ; 25 cm.
New horizons in competition law and economics.
Formatted Contents Note
Biopharmaceutical R&D : the increased importance of cumulative innovation and related concerns The patent system as a system of balancing The patent system and some potential safety nets The right to health as an interpretive principle of patent law Unilateral conduct, IPRs and competition law : a systems' interaction The duty to deal under Art. 82 EC The duty to deal as applied to address technology access problems in the biopharmaceutical industry.
Bibliography, etc. Note
Includes bibliographical references (pages 200-238) and index.